Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Harvard Business School
Deloitte
Citi
Argus Health
US Department of Justice
Dow
Merck

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018613

« Back to Dashboard

NDA 018613 describes OVIDE, which is a drug marketed by Taro Pharm and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the OVIDE profile page.

The generic ingredient in OVIDE is malathion. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the malathion profile page.
Summary for 018613
Tradename:OVIDE
Applicant:Taro Pharm
Ingredient:malathion
Patents:2
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Pharmacology for NDA: 018613
Mechanism of ActionCholinesterase Inhibitors
Medical Subject Heading (MeSH) Categories for 018613
Suppliers and Packaging for NDA: 018613
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OVIDE malathion LOTION;TOPICAL 018613 NDA TARO PHARMACEUTICALS USA, INC. 51672-5276 N 51672-5276-4
OVIDE malathion LOTION;TOPICAL 018613 NDA TARO PHARMACEUTICALS U.S.A., INC. 51672-5277 N 51672-5277-4

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.5%
Approval Date:Aug 2, 1982TE:ATRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Feb 1, 2027Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF PATIENTS INFECTED WITH PEDICULUS HUMANUS CAPITIS (HEAD LICE AND THEIR OVA) OF THE SCALP HAIR
Patent:➤ Try a Free TrialPatent Expiration:Aug 14, 2026Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Moodys
AstraZeneca
McKesson
Federal Trade Commission
Cerilliant
Chubb
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.